ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 3.745
+0.270 (7.77%)
Jul 6, 2026, 4:35 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 21.68 million as of July 6, 2026. Its market cap has increased by 87.41% in one year.
Market Cap
21.68M
Enterprise Value
20.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.75
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 21.68M, a decrease of -39.96%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 21.68M | -30.44% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 49.12M |
| Poolbeg Pharma | 48.30M |
| Sareum Holdings | 29.10M |
| SkinBioTherapeutics | 27.21M |
| Arecor Therapeutics | 23.98M |
| IXICO | 17.99M |
| Aptamer Group | 16.41M |
| Fusion Antibodies | 15.00M |